Novo Nordisk announces investment at its manufacturing site at France, generates 500 new jobs
Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases. The investment will significantly increase the capacity of the ma…
